An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1This trial is testing a new topical eye drop called DFL24498 against a vehicle control — what does 'vehicle' mean here, and does that mean some participants receive no active treatment for their dry eye during the study?
2. 2Since this is a Phase 2 trial, what does that tell us about how much is already known regarding DFL24498's safety and effectiveness compared to dry eye treatments that are already approved?
3. 3The trial is measuring improvement using the NEI corneal fluorescein staining scale, which assesses surface damage to the eye — can you help me understand what my current score on that scale is and whether that makes this trial worth discussing as an option for me?
4. 4The trial isn't recruiting yet — given that timeline uncertainty, would it make more sense to start an existing approved treatment now and revisit this trial later, or could waiting potentially be worthwhile?
5. 5Are there any aspects of my overall health history or current dry eye severity that might affect whether this kind of investigational topical solution would even be appropriate for me to discuss with the trial team?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.